Sign up to save your podcasts
Or
Share Season 4: Episode 2 - ICH Guidelines for CMC Development of Biologics/Biosimilars
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Season 4: Episode 2 - ICH Guidelines for CMC Development of Biologics/Biosimilars
Episode 2 will detail the various guidelines for biological product development and approval in the market. The reference guidelines discussed in the podcast will include the following:
- Guidelines that describe the expression construct, cloning, cell bank preparation, and characterization of biological products.
Our Regulatory experts will share more details about the subsidiary guidelines to be referred by a pharma company for streamlining Biologics development.
View all episodes
By Freyr SolutionsEpisode 2 will detail the various guidelines for biological product development and approval in the market. The reference guidelines discussed in the podcast will include the following:
- Guidelines that describe the expression construct, cloning, cell bank preparation, and characterization of biological products.
Our Regulatory experts will share more details about the subsidiary guidelines to be referred by a pharma company for streamlining Biologics development.